|
WO2020191503A1
|
|
Methods and uses of bromantane and derivatives thereof for treating lung disease, fatty liver disease, and kidney disorders
|
|
WO2020191502A1
|
|
Use of emoxypine and derivatives thereof for treating kidney disorders and inflammatory bowel disease
|
|
WO2020191501A1
|
|
Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
|
|
WO2020163966A1
|
|
Compositions and methods for treating idiopathic pulmonary fibrosis
|
|
WO2021003553A1
|
|
Compounds for treatment of diarrhea, inflammatory bowel disease and methods thereof
|
|
CA3105834A1
|
|
Compounds for treatment of inflammatory bowel disease and methods thereof
|
|
CA3105850A1
|
|
Compositions and methods for treating non-alcoholic steatohepatitis
|
|
CA3105127A1
|
|
The use of actarit in the prophylaxis or treatment of renal fibrosis or kidney disease
|
